Heart tumors pose a rare but significant challenge within the realm of cancer research. These growths, whether benign or malignant, demand specialized attention due to their unique location and potential impact on cardiac function. Diagnosis often requires a combination of advanced imaging modalities and biopsy procedures, enabling clinicians to accurately assess the nature of the tumor. Understanding the genetic and molecular signatures of these tumors is paramount, driving efforts to identify biomarkers for early detection and prognosis. Additionally, researchers are exploring targeted therapeutic approaches to effectively manage heart tumors, striving for improved outcomes and quality of life for affected individuals. Collaboration between oncologists, cardiologists, and researchers is fundamental in advancing our understanding and treatment of these intricate conditions, underscoring the importance of interdisciplinary efforts in oncology.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China